What do you see as most desirable for PER, Interested in your thoughts @George.
PARTNERSHIP TIMING
AFTER Trial readout (assuming results repeat ph2a);
- more $ upfront as partner has less risk having seen results
- after fda approval (CR to get there) then damand big bucks
Advantage; could gain massive deal with fda partial approval getting true value upfront ie hundreds of millions
BEFORE Trial readout as per your hunch;
- increase sp and cash position early from a deal to then negotiate from a less needy position for the remaining half? of the world market
Advantage;
- upon release of data results sp may fly higher given CR is not immediately on the horizon
- look at dxb having just 10m upfront they have continued to 6 bag in 6 months thanks to the credibility from this early partnership with CR along the way to further bolster their negotiation power $$ for future licencing deal ie usa and china
thanks
- Forums
- ASX - By Stock
- PER - Megathread
What do you see as most desirable for PER, Interested in your...
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
-0.001(1.12%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.5¢ | $80.35K | 925.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4700 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 17237 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 130094 | 0.087 |
1 | 127579 | 0.086 |
2 | 125065 | 0.085 |
2 | 16110 | 0.084 |
2 | 68250 | 0.083 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 10300 | 1 |
0.089 | 17237 | 2 |
0.090 | 135003 | 2 |
0.091 | 82805 | 1 |
0.093 | 200000 | 2 |
Last trade - 15.07pm 05/06/2024 (20 minute delay) ? |
|
|||||
Last
8.8¢ |
  |
Change
-0.001 ( 1.12 %) |
|||
Open | High | Low | Volume | ||
8.7¢ | 8.8¢ | 8.5¢ | 159060 | ||
Last updated 15.17pm 05/06/2024 ? |
Featured News
PER (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online